$7.99 Billion is the total value of Artal Group S.A.'s 110 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 58.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BUFF | BLUE BUFFALO PET PRODS INC | $3,481,817,000 | +21.4% | 87,460,875 | 0.0% | 43.57% | +0.7% | |
| WW | WEIGHT WATCHERS INTL INC NEW | $1,876,127,000 | +43.9% | 29,443,300 | 0.0% | 23.48% | +19.4% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $499,413,000 | -13.3% | 58,274,650 | 0.0% | 6.25% | -28.0% | |
| SPY | New | SPDR S&P 500 ETF TRcall | $131,575,000 | – | 500,000 | +100.0% | 1.65% | – |
| BAC | Sell | BANK AMER CORPcall | $130,457,000 | -23.8% | 4,350,000 | -25.0% | 1.63% | -36.8% |
| GM | New | GENERAL MTRS COcall | $127,190,000 | – | 3,500,000 | +100.0% | 1.59% | – |
| BGNE | Buy | BEIGENE LTDsponsored adr | $100,800,000 | +243.8% | 600,000 | +100.0% | 1.26% | +185.3% |
| IBM | Sell | INTERNATIONAL BUSINESS MACHScall | $92,058,000 | -25.0% | 600,000 | -25.0% | 1.15% | -37.8% |
| GS | Buy | GOLDMAN SACHS GROUP INCcall | $88,151,000 | +73.0% | 350,000 | +75.0% | 1.10% | +43.4% |
| XOM | New | EXXON MOBIL CORPcall | $74,610,000 | – | 1,000,000 | +100.0% | 0.93% | – |
| NKTR | Buy | NEKTAR THERAPEUTICS | $74,382,000 | +211.4% | 700,000 | +75.0% | 0.93% | +158.6% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $71,460,000 | +25.0% | 600,000 | +33.3% | 0.89% | +3.7% |
| WFC | Sell | WELLS FARGO CO NEWcall | $68,133,000 | -25.1% | 1,300,000 | -13.3% | 0.85% | -37.9% |
| CELG | Buy | CELGENE CORPcall | $57,987,000 | +270.4% | 650,000 | +333.3% | 0.73% | +207.6% |
| CVX | New | CHEVRON CORP NEWcall | $57,020,000 | – | 500,000 | +100.0% | 0.71% | – |
| BMY | BRISTOL MYERS SQUIBB COcall | $56,925,000 | +3.2% | 900,000 | 0.0% | 0.71% | -14.4% | |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $48,750,000 | +169.3% | 1,250,000 | +25.0% | 0.61% | +123.4% |
| INCY | Buy | INCYTE CORPcall | $45,832,000 | +93.6% | 550,000 | +120.0% | 0.57% | +60.8% |
| XBI | Buy | SPDR SERIES TRUSTcall | $43,865,000 | +29.2% | 500,000 | +25.0% | 0.55% | +7.2% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $41,265,000 | +447.2% | 450,000 | +350.0% | 0.52% | +352.6% |
| AGIO | AGIOS PHARMACEUTICALS INC | $40,890,000 | +43.0% | 500,000 | 0.0% | 0.51% | +18.8% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $37,600,000 | +161.3% | 2,500,000 | +150.0% | 0.47% | +117.1% |
| TSRO | Buy | TESARO INC | $34,284,000 | +313.7% | 600,000 | +500.0% | 0.43% | +243.2% |
| XLRN | Buy | ACCELERON PHARMA INC | $33,235,000 | +4.4% | 850,000 | +13.3% | 0.42% | -13.3% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $32,640,000 | +70.0% | 2,000,000 | +33.3% | 0.41% | +40.7% |
| CAT | New | CATERPILLAR INC DELcall | $29,476,000 | – | 200,000 | +100.0% | 0.37% | – |
| BLUE | BLUEBIRD BIO INC | $25,613,000 | -4.1% | 150,000 | 0.0% | 0.32% | -20.3% | |
| INCY | Sell | INCYTE CORP | $24,999,000 | -47.2% | 300,000 | -40.0% | 0.31% | -56.2% |
| MDCO | MEDICINES COcall | $23,058,000 | +20.5% | 700,000 | 0.0% | 0.29% | 0.0% | |
| NKTR | Sell | NEKTAR THERAPEUTICScall | $21,252,000 | -67.6% | 200,000 | -81.8% | 0.27% | -73.2% |
| AVXS | Buy | AVEXIS INC | $19,773,000 | +19.1% | 160,000 | +6.7% | 0.25% | -1.2% |
| ANAB | Buy | ANAPTYSBIO INC | $19,775,000 | +30.9% | 190,000 | +26.7% | 0.25% | +8.3% |
| ALBO | Buy | ALBIREO PHARMA INC | $17,843,000 | +132.3% | 547,841 | +82.6% | 0.22% | +92.2% |
| FCX | Buy | FREEPORT-MCMORAN INCcall | $17,570,000 | +270.7% | 1,000,000 | +300.0% | 0.22% | +209.9% |
| REGN | REGENERON PHARMACEUTICALScall | $17,218,000 | -8.4% | 50,000 | 0.0% | 0.22% | -24.3% | |
| ALXN | Sell | ALEXION PHARMACEUTICALS INCcall | $16,719,000 | -78.5% | 150,000 | -76.9% | 0.21% | -82.2% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INCcall | $16,298,000 | -45.6% | 100,000 | -50.0% | 0.20% | -54.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INCcall | $16,214,000 | +81.8% | 200,000 | +100.0% | 0.20% | +51.5% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $16,107,000 | +30.4% | 100,000 | +33.3% | 0.20% | +8.6% |
| FOLD | Sell | AMICUS THERAPEUTICS INCcall | $13,536,000 | -32.8% | 900,000 | -35.7% | 0.17% | -44.4% |
| CLVS | Buy | CLOVIS ONCOLOGY INCcall | $13,200,000 | +29.4% | 250,000 | +66.7% | 0.16% | +7.1% |
| AGEN | Buy | AGENUS INC | $12,953,000 | +58.9% | 2,750,000 | +10.0% | 0.16% | +31.7% |
| ARGX | Sell | ARGENX SEsponsored adr | $12,066,000 | -4.5% | 150,000 | -25.0% | 0.15% | -20.5% |
| IQ | New | IQIYI INCsponsored ads | $11,663,000 | – | 750,000 | +100.0% | 0.15% | – |
| FGEN | New | FIBROGEN INC | $11,550,000 | – | 250,000 | +100.0% | 0.14% | – |
| AXDX | ACCELERATE DIAGNOSTICS INC | $11,425,000 | -12.8% | 500,000 | 0.0% | 0.14% | -27.8% | |
| RDUS | Sell | RADIUS HEALTH INC | $10,782,000 | -15.2% | 300,000 | -25.0% | 0.14% | -29.7% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $9,660,000 | -29.9% | 200,000 | -42.9% | 0.12% | -41.8% |
| XNCR | Buy | XENCOR INC | $8,994,000 | +310.3% | 300,000 | +200.0% | 0.11% | +242.4% |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $8,934,000 | – | 300,000 | +100.0% | 0.11% | – |
| ZFGN | Buy | ZAFGEN INC | $8,940,000 | +93.5% | 1,200,000 | +20.0% | 0.11% | +60.0% |
| DNLI | Sell | DENALI THERAPEUTICS INC | $8,861,000 | +13.3% | 450,000 | -10.0% | 0.11% | -5.9% |
| TSRO | Buy | TESARO INCcall | $8,571,000 | +313.7% | 150,000 | +500.0% | 0.11% | +245.2% |
| FATE | New | FATE THERAPEUTICS INC | $8,296,000 | – | 850,000 | +100.0% | 0.10% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INCcall | $8,293,000 | – | 100,000 | +100.0% | 0.10% | – |
| ZGNX | New | ZOGENIX INC | $8,010,000 | – | 200,000 | +100.0% | 0.10% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $7,774,000 | – | 460,000 | +100.0% | 0.10% | – |
| RGNX | REGENXBIO INC | $7,463,000 | -10.2% | 250,000 | 0.0% | 0.09% | -25.6% | |
| VTL | Buy | VITAL THERAPIES INC | $6,800,000 | +30.6% | 1,000,000 | +14.3% | 0.08% | +7.6% |
| MDCO | MEDICINES CO | $6,588,000 | +20.5% | 200,000 | 0.0% | 0.08% | 0.0% | |
| ACIU | Buy | AC IMMUNE SA | $6,204,000 | -3.1% | 600,000 | +20.0% | 0.08% | -19.6% |
| STML | Buy | STEMLINE THERAPEUTICS INC | $6,120,000 | +96.2% | 400,000 | +100.0% | 0.08% | +63.8% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $6,015,000 | +86.1% | 150,000 | +62.9% | 0.08% | +53.1% |
| PRQR | PROQR THRAPEUTICS N V | $5,843,000 | -4.7% | 1,900,000 | 0.0% | 0.07% | -20.7% | |
| GLYC | Buy | GLYCOMIMETICS INC | $5,275,000 | +25.7% | 325,000 | +30.0% | 0.07% | +4.8% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $5,256,000 | – | 45,000 | +100.0% | 0.07% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $5,196,000 | – | 400,000 | +100.0% | 0.06% | – |
| ADRO | Buy | ADURO BIOTECH INC | $5,115,000 | +241.0% | 550,000 | +175.0% | 0.06% | +178.3% |
| IDRA | New | IDERA PHARMACEUTICALS INC | $5,060,000 | – | 2,750,000 | +100.0% | 0.06% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORPcall | $4,963,000 | – | 250,000 | +100.0% | 0.06% | – |
| SPRO | SPERO THERAPEUTICS INC | $4,988,000 | +21.3% | 350,000 | 0.0% | 0.06% | 0.0% | |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $4,688,000 | – | 250,000 | +100.0% | 0.06% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $4,632,000 | – | 300,000 | +100.0% | 0.06% | – |
| AKBA | New | AKEBIA THERAPEUTICS INC | $4,527,000 | – | 475,000 | +100.0% | 0.06% | – |
| BPMC | New | BLUEPRINT MEDICINES CORPcall | $4,585,000 | – | 50,000 | +100.0% | 0.06% | – |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $4,508,000 | -27.9% | 150,000 | -25.0% | 0.06% | -40.4% |
| NG | New | NOVAGOLD RES INC | $4,330,000 | – | 1,000,000 | +100.0% | 0.05% | – |
| TORC | New | RESTORBIO INC | $4,311,000 | – | 450,000 | +100.0% | 0.05% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $4,063,000 | – | 425,000 | +100.0% | 0.05% | – |
| AGIO | Sell | AGIOS PHARMACEUTICALS INCcall | $4,089,000 | -28.5% | 50,000 | -50.0% | 0.05% | -40.7% |
| SYBX | Sell | SYNLOGIC INC | $3,752,000 | -29.7% | 400,000 | -27.3% | 0.05% | -41.2% |
| IFRX | New | INFLARX NV | $3,605,000 | – | 125,000 | +100.0% | 0.04% | – |
| MGEN | Buy | MIRAGEN THERAPEUTICS INC | $3,505,000 | +236.0% | 500,000 | +400.0% | 0.04% | +175.0% |
| TGTX | Sell | TG THERAPEUTICS INC | $3,550,000 | +8.2% | 250,000 | -37.5% | 0.04% | -10.2% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $3,346,000 | -56.8% | 216,879 | -58.0% | 0.04% | -64.1% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $3,266,000 | -55.3% | 100,000 | -33.3% | 0.04% | -62.7% |
| CMTA | New | CLEMENTIA PHARMACEUTICALS IN | $3,030,000 | – | 200,000 | +100.0% | 0.04% | – |
| SGMO | New | SANGAMO THERAPEUTICS INC | $2,850,000 | – | 150,000 | +100.0% | 0.04% | – |
| ACHN | ACHILLION PHARMACEUTICALS IN | $2,783,000 | +28.8% | 750,000 | 0.0% | 0.04% | +6.1% | |
| CMRX | CHIMERIX INC | $2,600,000 | +12.3% | 500,000 | 0.0% | 0.03% | -5.7% | |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $2,320,000 | – | 400,000 | +100.0% | 0.03% | – |
| SNDX | SYNDAX PHARMACEUTICALS INC | $2,135,000 | +62.5% | 150,000 | 0.0% | 0.03% | +35.0% | |
| MRNS | Buy | MARINUS PHARMACEUTICALS INC | $1,910,000 | +17.0% | 500,000 | +150.0% | 0.02% | -4.0% |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $1,898,000 | -60.5% | 90,000 | -64.0% | 0.02% | -66.7% |
| KURA | KURA ONCOLOGY INC | $1,875,000 | +22.5% | 100,000 | 0.0% | 0.02% | 0.0% | |
| FIXX | New | HOMOLOGY MEDICINES INC | $1,870,000 | – | 100,000 | +100.0% | 0.02% | – |
| NERV | Buy | MINERVA NEUROSCIENCES INC | $1,875,000 | +23.4% | 300,000 | +19.4% | 0.02% | 0.0% |
| KRYS | KRYSTAL BIOTECH INC | $1,514,000 | -4.1% | 150,000 | 0.0% | 0.02% | -20.8% | |
| LIFE | ATYR PHARMA INC | $1,325,000 | -24.3% | 500,000 | 0.0% | 0.02% | -34.6% | |
| SELB | New | SELECTA BIOSCIENCES INC | $1,274,000 | – | 125,000 | +100.0% | 0.02% | – |
| TOCA | TOCAGEN INC | $1,185,000 | +15.6% | 100,000 | 0.0% | 0.02% | 0.0% | |
| TRILLIUM THERAPEUTICS INC | $1,080,000 | -0.7% | 150,000 | 0.0% | 0.01% | -12.5% | ||
| SLDB | New | SOLID BIOSCIENCES INC | $1,125,000 | – | 150,000 | +100.0% | 0.01% | – |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $1,143,000 | -2.6% | 25,000 | -50.0% | 0.01% | -22.2% |
| NVAX | NOVAVAX INC | $1,050,000 | +69.4% | 500,000 | 0.0% | 0.01% | +44.4% | |
| NVLNF | NOVELION THERAPEUTICS INC | $897,000 | +12.1% | 256,400 | 0.0% | 0.01% | -8.3% | |
| EDIT | Sell | EDITAS MEDICINE INC | $829,000 | -46.1% | 25,000 | -50.0% | 0.01% | -56.5% |
| XENE | XENON PHARMACEUTICALS INC | $735,000 | +73.3% | 150,000 | 0.0% | 0.01% | +50.0% | |
| OCX | ONCOCYTE CORPORATION | $315,000 | -54.9% | 150,000 | 0.0% | 0.00% | -63.6% | |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -350,336 | -100.0% | -0.02% | – |
| NK | Exit | NANTKWEST INC | $0 | – | -225,000 | -100.0% | -0.02% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.02% | – |
| NLNK | Exit | NEWLINK GENETICS CORPcall | $0 | – | -200,000 | -100.0% | -0.02% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.03% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -100,000 | -100.0% | -0.03% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.03% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -500,000 | -100.0% | -0.04% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -250,000 | -100.0% | -0.04% | – |
| CRBP | Exit | CORBUS PHARMACEUTICALS HLDGS | $0 | – | -400,000 | -100.0% | -0.04% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -100,000 | -100.0% | -0.04% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -500,000 | -100.0% | -0.04% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.05% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -1,000,000 | -100.0% | -0.05% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.05% | – |
| RDUS | Exit | RADIUS HEALTH INCcall | $0 | – | -100,000 | -100.0% | -0.05% | – |
| BTX | Exit | BIOTIME INC | $0 | – | -1,557,050 | -100.0% | -0.05% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -200,000 | -100.0% | -0.06% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.07% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponsored adr | $0 | – | -700,000 | -100.0% | -0.07% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.09% | – |
| VALE | Exit | VALE S Acall | $0 | – | -500,000 | -100.0% | -0.09% | – |
| ARRY | Exit | ARRAY BIOPHARMA INCcall | $0 | – | -500,000 | -100.0% | -0.10% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -100,000 | -100.0% | -0.10% | – |
| HZNP | Exit | HORIZON PHARMA PLCcall | $0 | – | -500,000 | -100.0% | -0.11% | – |
| ZTO | Exit | ZTO EXPRESS CAYMAN INCcall | $0 | – | -500,000 | -100.0% | -0.12% | – |
| BLUE | Exit | BLUEBIRD BIO INCcall | $0 | – | -50,000 | -100.0% | -0.13% | – |
| MET | Exit | METLIFE INCcall | $0 | – | -250,000 | -100.0% | -0.19% | – |
| JUNO | Exit | JUNO THERAPEUTICS INCcall | $0 | – | -350,000 | -100.0% | -0.24% | – |
| AMGN | Exit | AMGEN INCcall | $0 | – | -100,000 | -100.0% | -0.26% | – |
| BHF | Exit | BRIGHTHOUSE FINL INCcall | $0 | – | -300,000 | -100.0% | -0.26% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -250,000 | -100.0% | -0.29% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.38% | – |
| MS | Exit | MORGAN STANLEYcall | $0 | – | -500,000 | -100.0% | -0.40% | – |
| AGN | Exit | ALLERGAN PLCcall | $0 | – | -200,000 | -100.0% | -0.49% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDcall | $0 | – | -200,000 | -100.0% | -0.52% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -1,250,000 | -100.0% | -1.35% | – |
| C | Exit | CITIGROUP INCcall | $0 | – | -1,500,000 | -100.0% | -1.68% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.